Byard RW, Musgrave I, Maker G, Bunce M. What risks do herbal products pose to the Australian community? Med J Aust 2017;206(2):86–90. https://www.ncbi.nlm.nih.gov/pubmed/28152355
Izzo AA, Hoon-Kim S, Radhakrishnan R, Williamson EM. A critical approach to evaluating clinical efficacy, adverse events and drug interactions of herbal remedies. Phytother Res 2016;30(5):691–700. https://www.ncbi.nlm.nih.gov/pubmed/26887532
Morin CM, Edinger JD, Beaulieu-Bonneau S, Ivers H, Krystal AD, Guay B, et al. Effectiveness of sequential psychological and medication therapies for insomnia disorder: a randomized clinical trial. JAMA Psychiatry 2020. https://www.ncbi.nlm.nih.gov/pubmed/32639561
Qaseem A, Kansagara D, Forciea MA, Cooke M, Denberg TD, Clinical Guidelines Committee of the American College of P. Management of chronic insomnia disorder in adults: a clinical practice guideline from the American College of Physicians. Ann Intern Med 2016;165(2):125–33. https://www.ncbi.nlm.nih.gov/pubmed/27136449
Ree M, Junge M, Cunnington D. Australasian Sleep Association position statement regarding the use of psychological/behavioral treatments in the management of insomnia in adults. Sleep Med 2017;36 Suppl 1:S43–S7. https://www.ncbi.nlm.nih.gov/pubmed/28648226
Riemann D, Baglioni C, Bassetti C, Bjorvatn B, Dolenc Groselj L, Ellis JG, et al. European guideline for the diagnosis and treatment of insomnia. J Sleep Res 2017;26(6):675–700. https://www.ncbi.nlm.nih.gov/pubmed/28875581
Taibi DM, Landis CA, Petry H, Vitiello MV. A systematic review of valerian as a sleep aid: safe but not effective. Sleep Med Rev 2007;11(3):209–30. https://www.ncbi.nlm.nih.gov/pubmed/17517355
Wilson S, Anderson K, Baldwin D, Dijk DJ, Espie A, Espie C, et al. British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders: An update. J Psychopharmacol 2019;33(8):923–47. https://www.ncbi.nlm.nih.gov/pubmed/31271339